First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Debora Wernitznig; Konstantinos Kiakos; Giorgia Del Favero; Nathalie Harrer; Herwig Machat; Annika Osswald; Michael A. Jakupec; Andreas Wernitznig; Wolfgang Sommergruber; Bernhard K. Keppler

doi:10.1039/c9mt00051h

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Debora Wernitznig (Corresponding author), Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	1044-1048
Number of pages	5
Journal	Metallomics: integrated biometal science
Volume	11
Issue number	6
DOIs	https://doi.org/10.1039/c9mt00051h
Publication status	Published - 1 Jun 2019

Austrian Fields of Science 2012

104003 Inorganic chemistry
301904 Cancer research
106023 Molecular biology

Keywords

CANCER
MODELS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1039/c9mt00051hLicence: CC BY-NC 3.0

http://phaidra.univie.ac.at/o:1076896Licence: CC BY-NC 3.0

Cite this

Wernitznig, D., Kiakos, K., Del Favero, G., Harrer, N., Machat, H., Osswald, A., Jakupec, M. A., Wernitznig, A., Sommergruber, W., & Keppler, B. K. (2019). First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro. Metallomics: integrated biometal science, 11(6), 1044-1048. https://doi.org/10.1039/c9mt00051h

@article{e5110f1191134cc98f5d4154adc19ac5,

title = "First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro",

keywords = "CANCER, MODELS",

author = "Debora Wernitznig and Konstantinos Kiakos and {Del Favero}, Giorgia and Nathalie Harrer and Herwig Machat and Annika Osswald and Jakupec, {Michael A.} and Andreas Wernitznig and Wolfgang Sommergruber and Keppler, {Bernhard K.}",

note = "Publisher Copyright: {\textcopyright} The Royal Society of Chemistry.",

year = "2019",

month = jun,

day = "1",

doi = "10.1039/c9mt00051h",

language = "English",

volume = "11",

pages = "1044--1048",

journal = "Metallomics: integrated biometal science",

issn = "1756-5901",

publisher = "ROYAL SOC CHEMISTRY",

number = "6",

}

Wernitznig, D, Kiakos, K, Del Favero, G, Harrer, N, Machat, H, Osswald, A, Jakupec, MA, Wernitznig, A, Sommergruber, W & Keppler, BK 2019, 'First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro', Metallomics: integrated biometal science, vol. 11, no. 6, pp. 1044-1048. https://doi.org/10.1039/c9mt00051h

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro. / Wernitznig, Debora (Corresponding author); Kiakos, Konstantinos; Del Favero, Giorgia et al.
In: Metallomics: integrated biometal science, Vol. 11, No. 6, 01.06.2019, p. 1044-1048.

Publications: Contribution to journal › Article › Peer Reviewed

TY - JOUR

T1 - First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

AU - Wernitznig, Debora

AU - Kiakos, Konstantinos

AU - Del Favero, Giorgia

AU - Harrer, Nathalie

AU - Machat, Herwig

AU - Osswald, Annika

AU - Jakupec, Michael A.

AU - Wernitznig, Andreas

AU - Sommergruber, Wolfgang

AU - Keppler, Bernhard K.

PY - 2019/6/1

Y1 - 2019/6/1

KW - CANCER

KW - MODELS

UR - http://www.scopus.com/inward/record.url?scp=85067550202&partnerID=8YFLogxK

U2 - 10.1039/c9mt00051h

DO - 10.1039/c9mt00051h

M3 - Article

SN - 1756-5901

VL - 11

SP - 1044

EP - 1048

JO - Metallomics: integrated biometal science

JF - Metallomics: integrated biometal science

IS - 6

ER -

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this